#My favorite chaperone rising action movie#

Mel Odedra ( Bad behavior, good balance, bad seed), Jonathan Martin Mustaq Missouri ( Rūrangi, The Gulf, A Good Balance) roy snow ( Little Shop of Horrors, The Stolen, The Shannara Chronicles), Nicholas Kawana ( Astroman, Brokenwood Mysteries, Shortland Street), Andy Grainger ( Jersey Boys, Six Degrees of Separation, The Breaker Uppers), michele hine ( Headsand, The Pact, Go Girls), Joining Prebble and O’Kane is a terrific cast, including

#My favorite chaperone rising action movie#

Complete with car chases, plane crashes and the cliffhanger ending at Mount Rushmore, the twists, turns and tensions of Hitchcock’s movie sensation are brought to life on stage in this fast-paced stage adaptation. Thornhill’s life is turned upside down when a case of mistaken identity turns him into a framed fugitive thrown into a world of espionage, mystery and romance.įrom New York to North Dakota, Thornhill is pursued by spies, feds, and blonde genius Eve Kendall. In north by northwestSuccessful and suave Madison Avenue advertising executive Roger O. In the role made famous by movie star Cary Grant in Hitchcock’s original film, the award-winning New Zealand actor Ryan O’Kane ( One Lane Bridge, The Justice of Bunny King, A Streetcar Named Desire) makes his Auckland Theater Company debut as the lead man on the run, Roger O. Having graced local and international television and movie screens for many years, in north by northwest Prebble makes headlines as the glamorous and witty double agent, Eve Kendall. Renowned actress Antonia Prebble ( Westside, goodbye pork pie, outrageous fortune) makes her return to the stage after nine years, last seen taking to the stage in Auckland Theater Company’s acclaimed production of It’s one of my favorites because by adapting a classic film, it somehow doubles down on its resounding celebration of live theater and what a group of actors can do.” achieve if they turn their backs on him.Īnd what a fantastic collection of the best New Zealand actors I have to play! I can’t wait to start working with them, to bring to Auckland all the thrills, spills, wit and bang of our spirited tribute to Hitchcock’s masterpiece.” Says Simon Phillips, “Carolyn and I are delighted to be bringing this production to our homeland. Now, with an all-New Zealand cast of the country’s best acting talent, director and creator of north by northwest simon phillips ( Priscilla: Queen of the Desert, Love Never Dies, Muriel’s Wedding), one of Aotearoa’s most successful theatrical exports, returns home to direct its New Zealand premiere at the ASB Waterfront Theatre. Caroline Burns, has captivated audiences around the world since its world premiere season in 2015 at the Melbourne Theater Company. Price Action: CNTA shares closed 3.28% lower at $5.01 on Tuesday.Auckland Theater Company rounds out the year with a thrilling Hitchcock show, starring Antonia Prebble and Ryan O’KaneĪ bold reimagining of Alfred Hitchcock’s beloved classic film into a play, by the writer and the theatre. It looks forward to initiating clinical trials with LB101 (PD-L1xCD47) for solid tumors after planned IND filing late this year.Ĭentessa ended the June quarter with cash and cash equivalents of $484.2 million, sufficient to fund operations into 2026. The company remains on track to initiate registrational studies for SerpinPC for Hemophilia B in the second half of this year. ZF874, a pharmacological chaperone designed to rescue the folding of the Z variant of alpha-1-antitrypsin (A1AT), was in a Phase 1 study to treat AATD.Īs previously reported in November 2021, elevated liver enzymes were observed in a subject dosed with 15 mg/kg BID of ZF874 in the first cohort of patients within Part B of the Phase 1 study.īased on the results observed, the company concluded that ZF874 was unlikely to achieve the desired target product profile. Centessa Pharmaceuticals plc (NASDAQ: CNTA) has decided to discontinue the development of ZF874 following a recent report of an adverse event involving elevated liver enzymes (AST/ALT) in a PiMZ subject dosed with 5 mg/kg in the Phase 1 study.